Genomix Agri Genetics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 84.91%
(FY 2023)
- Profit 507.94%
(FY 2023)
- Ebitda 584.16%
(FY 2023)
- Net Worth 300.31%
(FY 2023)
- Total Assets 191.89%
(FY 2023)
About Genomix Agri Genetics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Gundavaram and Chennamaneni Vamsheedhar serve as directors at the Company.
- CIN/LLPIN
U01110TG2017PTC120071
- Company No.
120071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2017
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genomix Agri Genetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gundavaram  | Director | 16-Oct-2017 | Current |
| Chennamaneni Vamsheedhar | Director | 16-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Genomix Agri Genetics.
Genomix Agri Genetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 84.91% increase. The company also saw a substantial improvement in profitability, with a 507.94% increase in profit. The company's net worth Soared by an impressive increase of 300.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomix Agri Genetics?
In 2023, Genomix Agri Genetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kaveri Seed Company Ltd.Active 38 years 3 monthsVenkata Gundavaram and Chennamaneni Vamsheedhar are mutual person
- Aditya Agri Tech Private LimitedActive 11 years 8 months
Venkata Gundavaram and Chennamaneni Vamsheedhar are mutual person
- Kaveri Bhaskar Rao Charitable FoundationActive 8 years 4 months
Venkata Gundavaram is a mutual person
- Genome Agritech Private LimitedActive 19 years 11 months
Venkata Gundavaram and Chennamaneni Vamsheedhar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genomix Agri Genetics?
Genomix Agri Genetics has a workforce of 98 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomix Agri Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Agri Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
